The allergenicity of genetically modified foods - from genetically engineered crops - A narrative and systematic review

Annals of Allergy, Asthma & Immunology

September  2017 Volume 119, Issue 3, Pages 214-222 CME Review

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee Members:
S. Eliza Dunn, MD, (Author)
John L. Vicini, PhD,  (Author)
Kevin C. Glenn, PhD, (Author)
David Fleischer, MD, (Author)
Matthew Greenhawt, MD, MBA, MSc, (Author)
Jonathan A. Bernstein, MD (CME Subcommittee)
Guha Krishnaswamy, MD (CME Subcommittee)
John J. Oppenheimer, MD (CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:
Recognize the testing and safety features that genetically modified products are subject to in determining their allergenicity
Identify the basis and rationale for genetic modification
Review the evidence regarding genetically modified products and any association with food allergy 

Additional information
Disclosure: 

S.E.Dunn; D.M. Fleischer; K.C. Glenn; J.L. Vicini have no relevant financial relationships to disclose. Any unapproved/investigative uses of therapeutic agents/devices discussed are appropriately noted. M. Greenhawt – Advisory Board for Monsanto; he received a research grant and fees; J.A. Bernstein – PI, Consultant, Speaker for AstraZeneca, CSL Behring, Novartis/Genentech, and Shire, he received research grants and fees; Speaker for Baxalta, he received fees; Consultant for Imedics, he received fees; PI and Consultant for Boehringer Ingelheim and GlaxoSmithKline, he received research grants and fees. G. Krishnaswamy – Clinical Research for CSL Behring, he received a research grant; J. Oppenheimer – Consultant for DBV Technologies, GlaxoSmithKline, and Kaleo, he received other financial gains; Clinical research for AstraZeneca, Boehringer Ingelheim, and Novartis, he received research grants. M.H. Grayson – Clinical research for Polyphor, Ltd., he received a research grant. G.D. Marshall – Clinical Research for Stallergens and Sanofi, he received research grants

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
09/01/2017
Course expires: 
08/31/2019
Cost:
$0.00
Rating: 
0

Planning Committee Members:
Guha Krishnaswamy, MD (Author)
Sara Pasha, MD (Author)
Arjun B. Chatterjee, MD (Author)
Sandhya Kumar, MD (Author)
Anne K. Ellis, MD (Associate Editor)
Jonathan A. Bernstein, MD (CME Subcommittee)
John J. Oppenheimer, MD (CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
09/01/2017
Course expires: 
08/31/2019

Price

Cost:
$0.00
Please login or create an account to take this course.